Top Markets
#1 AntFun AntFun +67.30%
#2 BankrCoin BankrCoin +22.35%
#3 EXOD EXOD +21.04%
#4 ZetaChain ZetaChain +14.56%
#5 Fake World Assets Fake World Assets +14.54%
#6 Venom Venom +13.61%
#7 StonkBroker StonkBroker +10.38%
#8 Phala Phala +10.32%
#9 Black Phoenix Black Phoenix +10.31%
#10 CARV CARV +10.16%
Coin of the day
AntFun AntFun
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
Kedudukan dalam Saham #107
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Harga Saham
$41.14
Disegerakkan terakhir: 2026-09-21
Modal Pasaran
$182.76B
Perubahan (1 hari)
-7.78%
Perubahan (1 tahun)
-32.24%
Negara
DK
Perdagangan Novo Nordisk A/S (NOVO-B)

Kategori

Healthcare
Nisbah P/B bagi Novo Nordisk A/S (NOVO-B)
Nisbah P/B pada September 2026 TTM: 5.61
Menurut laporan kewangan dan harga saham terkini Novo Nordisk A/S, nisbah P/B semasa (TTM) ialah 5.61. Pada akhir 2024, nisbah P/B syarikat ialah 19.38.
Sejarah nisbah P/B untuk Novo Nordisk A/S dari 2000 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
2026 (TTM) 5.61 -24.68%
2025 7.45 -61.56%
2024 19.38 -34.02%
2023 29.37 15.39%
2022 25.45 6.65%
2021 23.87 51.77%
2020 15.72 -1.35%
2019 15.94 12.22%
2018 14.20 -14.34%
2017 16.58 16.48%
2016 14.23 -34.97%
2015 21.89 29.23%
2014 16.94 35.36%
2013 12.51 -0.67%
2012 12.60 26.42%
2011 9.97 0.88%
2010 9.88 77.44%
2009 5.57 9.91%
2008 5.07 -20.41%
2007 6.36 25.26%
2006 5.08 20.40%
2005 4.22 11.39%
2004 3.79 16.59%
2003 3.25 4.96%
2002 3.10 -47.14%
2001 5.86 -4.54%
2000 6.14 0.00%
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 29.9692 434.10%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.6479 36.30%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -78.0908 -1,491.70%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 8.4776 51.08%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 8.5385 52.17%
US